Back to Blog

Type 2 Diabetes: A Comprehensive Guide to India's Growing Health Challenge

D

Dr. Akshay Ambekar

28 February 2026

Type 2 Diabetes Diabetes Management Insulin Resistance HbA1c Endocrinology

The Diabetes Epidemic in India

India is often called the “Diabetes Capital of the World” — and for good reason. Over 101 million Indians are living with diabetes (mostly Type 2), and another 136 million have prediabetes. By 2045, these numbers are projected to rise dramatically.

Type 2 Diabetes Mellitus (T2DM) is a chronic metabolic disorder characterized by high blood sugar levels due to insulin resistance (the body’s cells don’t respond properly to insulin) combined with progressive beta-cell dysfunction (the pancreas gradually produces less insulin over time).

Unlike Type 1 diabetes, T2DM develops over years and is strongly linked to lifestyle, genetics, and metabolic factors.

What Causes Type 2 Diabetes?

T2DM results from a combination of factors:

1. Insulin Resistance

  • Body cells (muscle, fat, liver) become resistant to insulin’s action
  • The pancreas compensates by producing more insulin (hyperinsulinemia)
  • Over time, the pancreas cannot keep up — blood sugar rises
  • Central (abdominal) obesity is the strongest driver of insulin resistance

2. Beta-Cell Dysfunction

  • The insulin-producing cells in the pancreas gradually fail
  • At diagnosis, approximately 50% of beta-cell function is already lost
  • This is a progressive process — diabetes tends to worsen over time without proper management

3. Genetic Factors

  • Strong genetic component — if both parents have T2DM, risk is 70–80%
  • South Asians (Indians) have higher genetic susceptibility at lower BMI
  • Thrifty gene hypothesis — genes that helped survive famines now promote diabetes in an era of food abundance

4. Lifestyle and Environmental Factors

  • Sedentary lifestyle — physical inactivity reduces insulin sensitivity
  • Unhealthy diet — refined carbs, sugary drinks, processed foods
  • Obesity — especially abdominal obesity
  • Sleep deprivation — less than 6 hours increases diabetes risk
  • Chronic stress — elevates cortisol, promotes insulin resistance
  • Smoking — independent risk factor

Indian Phenotype — Why Indians Are More Vulnerable

  • Higher body fat percentage at lower BMI
  • More visceral (abdominal) fat
  • Greater insulin resistance
  • Lower muscle mass
  • Genetic predisposition
  • Diabetes develops at a younger age and lower BMI compared to Western populations

Symptoms of Type 2 Diabetes

Many people with T2DM have no symptoms for years — this is why screening is crucial.

When present, symptoms include:

  • Increased thirst (polydipsia)
  • Frequent urination (polyuria), especially at night
  • Unexplained fatigue
  • Blurred vision
  • Slow-healing wounds or frequent infections
  • Tingling or numbness in hands/feet (neuropathy)
  • Darkened skin patches (acanthosis nigricans) — neck, armpits, groin
  • Recurrent fungal infections — genital candidiasis

Important: Many Indians are diagnosed only when they develop a complication — heart attack, stroke, kidney failure, or foot ulcer. Don’t wait for symptoms.

How Is Type 2 Diabetes Diagnosed?

TestNormalPrediabetesDiabetes
Fasting Blood Sugar< 100 mg/dL100–125 mg/dL≥ 126 mg/dL
HbA1c< 5.7%5.7–6.4%≥ 6.5%
OGTT (2-hour post-glucose)< 140 mg/dL140–199 mg/dL≥ 200 mg/dL
Random Blood Sugar≥ 200 mg/dL (with symptoms)

Who should be screened?

  • All adults aged ≥ 35 years
  • Adults with BMI ≥ 23 kg/m² (Asian cut-off) with additional risk factors
  • Women with history of gestational diabetes
  • Persons with PCOS
  • Strong family history of diabetes

Understanding HbA1c — Your 3-Month Report Card

HbA1c reflects average blood sugar over the past 2–3 months:

HbA1cEstimated Average Blood SugarInterpretation
5.7%~117 mg/dLNormal
6.5%~140 mg/dLDiabetes threshold
7.0%~154 mg/dLTypical target for most adults
8.0%~183 mg/dLAbove target — needs intensification
9.0%~212 mg/dLPoorly controlled
10.0%~240 mg/dLVery poorly controlled

Target HbA1c for most adults: < 7.0% (individualized — may be stricter or more relaxed based on age, complications, and hypoglycemia risk)

Modern Treatment of Type 2 Diabetes

The Treatment Pyramid

Treatment follows a stepwise, individualized approach:

1. Lifestyle Modification (Foundation of Treatment)

Diet:

  • No single “diabetic diet” — individualize based on culture, preferences, and affordability
  • Reduce refined carbohydrates (maida, white rice, sugary drinks, sweets)
  • Choose complex carbs (whole wheat, brown rice, millets, oats)
  • Include adequate protein (dal, paneer, eggs, fish, chicken)
  • Increase fiber (vegetables, salads, whole grains)
  • Healthy fats (nuts, seeds, olive oil, mustard oil)
  • Portion control is key — even healthy foods matter in quantity
  • Limit fruit to 2 servings per day; avoid fruit juices

Exercise:

  • 150 minutes per week of moderate aerobic activity (brisk walking, cycling, swimming)
  • Resistance training 2–3 times per week
  • Reduce sitting time — walk every 30–60 minutes
  • Even 30 minutes of daily walking makes a significant difference

Weight Management:

  • Losing 5–10% of body weight dramatically improves blood sugar
  • Sustainable changes, not crash diets

2. Oral Medications

Metformin (First-Line Drug):

  • Reduces liver glucose output, improves insulin sensitivity
  • Modest weight loss or weight-neutral
  • Safe, affordable, and effective
  • Start low, increase gradually (reduces GI side effects)

SGLT2 Inhibitors (Empagliflozin, Dapagliflozin, Canagliflozin):

  • Block glucose reabsorption in the kidney
  • Proven cardiovascular and kidney benefits — reduce heart failure and kidney disease progression
  • Promote weight loss (2–3 kg)
  • Lower blood pressure
  • Side effects: genital yeast infections, urinary tract infections

GLP-1 Receptor Agonists (Liraglutide, Semaglutide, Dulaglutide):

  • Mimic the incretin hormone GLP-1
  • Significant weight loss (5–15%)
  • Cardiovascular benefits (heart attack and stroke reduction)
  • Reduce appetite naturally
  • Injectable (weekly or daily) or oral (oral semaglutide)

DPP-4 Inhibitors (Sitagliptin, Vildagliptin, Linagliptin):

  • Enhance the body’s own incretin system
  • Weight-neutral
  • Well-tolerated, few side effects
  • Modest HbA1c reduction

Sulfonylureas (Glimepiride, Gliclazide):

  • Stimulate insulin secretion from the pancreas
  • Effective and affordable
  • Risk of hypoglycemia and weight gain
  • Still widely used in India

Pioglitazone:

  • Improves insulin sensitivity
  • Useful in fatty liver and insulin-resistant patients
  • Can cause weight gain, edema, and fracture risk

3. Injectable Therapies

GLP-1 Receptor Agonists (discussed above)

Insulin Therapy:

  • Needed when oral medications and GLP-1 agonists cannot achieve targets
  • Not a failure — it’s a tool to protect your body from high sugar
  • Types:
    • Basal insulin (Glargine, Detemir, Degludec) — once daily, controls fasting sugar
    • Premixed insulin — combines basal and mealtime insulin
    • Basal-bolus regimen — most flexible, for intensive management
  • Modern insulins are safe, convenient, and cause less hypoglycemia than older formulations

4. Continuous Glucose Monitoring (CGM) in T2DM

CGM is no longer just for Type 1 diabetes:

  • Real-time glucose data helps understand how food, exercise, stress, and medications affect sugar
  • Identifies hidden highs and lows
  • Time-in-Range (TIR) provides a more complete picture than HbA1c alone
  • Motivates patients with visual feedback
  • Useful for patients on insulin or those with glucose variability

Complications of Type 2 Diabetes

Uncontrolled diabetes damages blood vessels and nerves throughout the body:

Microvascular Complications

  • Diabetic Retinopathy — eye damage, leading cause of blindness in working-age adults
  • Diabetic Nephropathy — kidney damage, leading cause of end-stage kidney disease
  • Diabetic Neuropathy — nerve damage causing numbness, pain, tingling in feet/hands

Macrovascular Complications

  • Coronary artery disease — heart attacks
  • Cerebrovascular disease — strokes
  • Peripheral arterial disease — poor circulation, gangrene, amputations

Other Complications

  • Diabetic foot — ulcers, infections, amputations (largely preventable with proper care)
  • Diabetic ketoacidosis (rare in T2DM, but can occur)
  • Infections — urinary tract, skin, fungal infections
  • Depression — 2–3 times more common in diabetes

Screening Schedule for Complications

ComplicationScreening TestFrequency
EyesDilated fundoscopyAnnual
KidneysUrine albumin, serum creatinine, eGFRAnnual
FeetComprehensive foot examEvery visit
HeartLipid profile, BP, ECGAnnual
NervesMonofilament testingAnnual

Prevention of Type 2 Diabetes

For those with prediabetes or high risk:

  • Lifestyle modification reduces diabetes risk by 58%
  • Weight loss of 5–7% is the most effective intervention
  • 150 minutes per week of physical activity
  • Metformin may be added for high-risk individuals

The Bottom Line

Type 2 diabetes is a serious but manageable condition. The landscape of diabetes treatment has transformed with modern medications that not only control blood sugar but also protect the heart, kidneys, and promote weight loss. The key is:

  1. Early diagnosis through screening
  2. Lifestyle modification as the foundation
  3. Individualized medication — not one-size-fits-all
  4. Regular monitoring and complication screening
  5. Long-term follow-up with your care team

“Diabetes doesn’t have to define your life. With the right treatment and consistent follow-up, you can live a full, active life while keeping diabetes under control.”

If you have diabetes or risk factors for diabetes, consult an endocrinologist for a comprehensive evaluation and personalized treatment plan that uses the latest evidence-based therapies.

Need an endocrine consultation?

Book an appointment with Dr. Akshay Ambekar for expert evaluation.

Call for Appointment